Search research articles
Contact Us
Filters
Showing results (141-150 of 194) with videos related to
Page
of 20
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 3, 2021
<sup>90</sup>Y Radioembolization in the Treatment of Neuroendocrine Neoplasms: Results of an International Multicenter Retrospective Study
Benedikt M Schaarschmidt, Moritz Wildgruber, Roman Kloeckner, et al.
Clinical Chemistry and Laboratory Medicine
|
May 6, 2024
Thyroglobulin measurement is the most powerful outcome predictor in differentiated thyroid cancer: a decision tree analysis in a European multicenter series
Luca Giovanella, Lisa Milan, Wolfgang Roll, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 24, 2020
PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [<sup>177</sup>Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis
Robert Seifert, Katharina Kessel, Katrin Schlack, et al.
Cancers
|
April 30, 2021
Predictive Factors for RAI-Refractory Disease and Short Overall Survival in PDTC
David Kersting, Robert Seifert, Lukas Kessler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 2, 2023
Efficacy and Safety of <sup>124</sup>I-MIBG Dosimetry-Guided High-Activity <sup>131</sup>I-MIBG Therapy of Advanced Pheochromocytoma or Neuroblastoma
Ines Maric, Manuel Weber, Andre Prochnow, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 23, 2018
Use of FET PET in glioblastoma patients undergoing neurooncological treatment including tumour-treating fields: initial experience
Garry Ceccon, Lazaros Lazaridis, Gabriele Stoffels, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 8, 2023
Voxel-Based Dosimetry Predicts Hepatotoxicity in Hepatocellular Carcinoma Patients Undergoing Radioembolization with <sup>90</sup>Y Glass Microspheres
Masao Watanabe, Hong Grafe, Jens Theysohn, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 29, 2022
Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria
Andrei Gafita, Isabel Rauscher, Wolfgang P Fendler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 12, 2020
Identification of PCWG3 Target Populations Is More Accurate and Reproducible with PSMA PET Than with Conventional Imaging: A Multicenter Retrospective Study
Andrea Farolfi, Nader Hirmas, Andrei Gafita, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 29, 2022
Artificial intelligence guided enhancement of digital PET: scans as fast as CT?
René Hosch, Manuel Weber, Miriam Sraieb, et al.
Page
of 20
Search research articles
Search
Showing results (141-150 of 194) with videos related to
Sort By:
Page
of 20
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 3, 2021
<sup>90</sup>Y Radioembolization in the Treatment of Neuroendocrine Neoplasms: Results of an International Multicenter Retrospective Study
Benedikt M Schaarschmidt, Moritz Wildgruber, Roman Kloeckner, et al.
Clinical Chemistry and Laboratory Medicine
|
May 6, 2024
Thyroglobulin measurement is the most powerful outcome predictor in differentiated thyroid cancer: a decision tree analysis in a European multicenter series
Luca Giovanella, Lisa Milan, Wolfgang Roll, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 24, 2020
PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [<sup>177</sup>Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis
Robert Seifert, Katharina Kessel, Katrin Schlack, et al.
Cancers
|
April 30, 2021
Predictive Factors for RAI-Refractory Disease and Short Overall Survival in PDTC
David Kersting, Robert Seifert, Lukas Kessler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 2, 2023
Efficacy and Safety of <sup>124</sup>I-MIBG Dosimetry-Guided High-Activity <sup>131</sup>I-MIBG Therapy of Advanced Pheochromocytoma or Neuroblastoma
Ines Maric, Manuel Weber, Andre Prochnow, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 23, 2018
Use of FET PET in glioblastoma patients undergoing neurooncological treatment including tumour-treating fields: initial experience
Garry Ceccon, Lazaros Lazaridis, Gabriele Stoffels, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 8, 2023
Voxel-Based Dosimetry Predicts Hepatotoxicity in Hepatocellular Carcinoma Patients Undergoing Radioembolization with <sup>90</sup>Y Glass Microspheres
Masao Watanabe, Hong Grafe, Jens Theysohn, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 29, 2022
Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria
Andrei Gafita, Isabel Rauscher, Wolfgang P Fendler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 12, 2020
Identification of PCWG3 Target Populations Is More Accurate and Reproducible with PSMA PET Than with Conventional Imaging: A Multicenter Retrospective Study
Andrea Farolfi, Nader Hirmas, Andrei Gafita, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 29, 2022
Artificial intelligence guided enhancement of digital PET: scans as fast as CT?
René Hosch, Manuel Weber, Miriam Sraieb, et al.
Page
of 20